ST. PAUL – New laws increasing emergency access to insulin and increasing transparency of prescription drug prices take effect July 1 in Minnesota. The Alec Smith Insulin Affordability Act allows diabetics with less than a one-week supply of insulin that otherwise do not have access to the drug to receive a 30-day emergency supply from a pharmacy.
To be eligible an individual must:
“Along with resources already available through medical assistance programs and insulin manufacturers themselves, the law provides an additional safety net for those without appropriate health insurance coverage,” said Rep. Dale Lueck, R-Aitkin.?“A reliable source of insulin is critical; this program is intended to prevent a lack of access from cascading into a life-threatening situation.”
Another new state law requires drug manufactures to begin reporting to the Minnesota Commissioner of Health, large price increases under the Prescription Drug Price Transparency Act. In addition to disclosing the manufacturing, marketing and distribution costs, manufacturers must report a variety of other detailed financial information.
For each prescription drug whose price was $100 or greater for a 30-day supply, or for a treatment lasting less than 30 days, manufacturers must report certain drug pricing information as follows:
“Drug cost increases remain a mystery to the average consumer,” Lueck said. “This law should help shine a light on what is actually triggering major drug cost increases.”
The law becomes effective July 1, with first reports due to the Minnesota Commissioner of Health on Oct. 1, 2021. The Commissioner is required to make the data available to the public. Summaries of laws passed during the 2020 Legislature regular session are available at http://www.house.mn/newlaws/#/search/2020.